Karyopharm Therapeutics



Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on discovery and development of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation.

Richard Paulson
President & CEO
Richard Paulson
Sharon Shacham
Co-Founder & Chief Scientific Officer
Michael G. Kauffman
Co-Founder & Senior Clinical Advisor
Stephen Mitchener
Chief Business Officer
Steven Rotman
Chief People & Corporate Engagement Officer
Jatin Shah
EVP & Chief Medical Officer
Ran Frenkel
EVP, Chief Development Officer
Mike Mano
SVP & General Counsel
Yosef Landesman
SVP, Research & Translational Medicine
Brian Austad
SVP, Pharmaceutical Sciences
Lisa Meletta
VP of Legal & Chief Compliance Officer
Ronit Milstein
VP, Operations
Anat Haas Mizrahi
GM, Karyopharm Israel
Payman Darouian
SVP, Marketing
Sohanya Cheng
Chief Commercial Officer
Eleonora Goldberg
SVP, Global Medical and Scientific Affairs

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.